- Question from A22: Is it possible to receive T-DM1 (chemical name: ado-trastuzumab emtansine) outside of a clinical trial or on a compassionate use basis?
- Answers - Kathy D. Miller, M.D. No. There are several ongoing clinical trials with this exciting new agent, but the drug is not yet approved and there is not a compassionate use program.
The Ask-the-Expert Online Conference called Updates From the 2009 San Antonio Breast Cancer Symposium featured Kathy Miller, M.D. and Kristin Brill, M.D., F.A.C.S. answering your questions about the latest updates on breast cancer risk, screening techniques, treatment options, and more.
Editor's Note: This conference took place in December 2009.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.